Early Human Development
Volume 86, Issue 3 , Pages 149-154 , March 2010

Functional echocardiography; from physiology to treatment

  • Koert de Waal

      Affiliations

    • Department of Neonatology, John Hunter Hospital and University of Newcastle, Newcastle, Australia
    • Corresponding Author InformationCorresponding author. Department of Neonatology, John Hunter Children's Hospital, Lookout Road, New Lambton NSW 3205, Australia. Tel.: +61 2 49214362; fax: +61 2 49214408.
  • ,
  • Martin Kluckow

      Affiliations

    • Department of Neonatology, Royal North Shore Hospital and University of Sydney, Sydney, Australia

References 

  1. Kluckow M, Seri I, Evans N. Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr. 2007;150:125–130
  2. Kluckow M, Seri I, Evans N. Echocardiography and the neonatologist. Pediatr Cardiol. 2008;29:1043–1047
  3. Mayo PH, Beaulieu Y, Doelken P, Feller-Kopman D, Harrod C, Kaplan A, et al. American College of Chest Physicians/La Société de Réanimation de Langue Française statement on competence in critical care ultrasonography. Chest. 2009;135:1050–1060
  4. Wright J, Jarman R, Connolly J, Dissmann P. Echocardiography in the emergency department. Emerg Med J. 2009;26:82–86
  5. Australasian Society for Ultrasound in Medicine: Certificate in Clinician Performed Ultrasound. Retrieved December 2009 from http://www.asum.com.au/ccpu.
  6. Dempsey EM, Al Hazzani F, Barrington KJ. Permissive hypotension in the extremely low birthweight infant with signs of good perfusion. Arch Dis Child Fetal Neonatal Ed. 2009;94:F241–F244
  7. Fanaroff JM, Wilson-Costello DE, Newman NS, Montpetite MM, Fanaroff AA. Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics. 2006;117:1131–1135
  8. Batton B, Zhu X, Fanaroff J, Kirchner HL, Berlin S, Wilson-Costello D, et al. Blood pressure, anti-hypotensive therapy, and neurodevelopment in extremely preterm infants. J Pediatr. 2009;154:351–357
  9. Osborn DA. Diagnosis and treatment of preterm transitional circulatory compromise. Early Hum Dev. May 2005;81:413–422
  10. Evans N. Assessment and support of the preterm circulation. Early Hum Dev. 2006;82:803–810
  11. Evans N, Kluckow M. Early determinants of right and left ventricular output in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed. 1996;74:F88–F94
  12. Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2000;82:F188–F194
  13. Lundstrøm K, Pryds O, Greisen G. The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Hum Dev. 2000;57:157–163
  14. Osborn D, Evans N, Kluckow M. Randomized trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. J Pediatr. 2002;140:183
  15. Paradisis M, Evans N, Kluckow M, Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr. 2009;154:189–195
  16. Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics. 2006;117:e1213–e1222
  17. Evans N, Iyer P. Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes. Arch Dis Child Fetal Neonatal Ed. 1995;72:F156–F161
  18. Groves AM, Kuschel CA, Knight DB, Skinner JR. Does retrograde diastolic flow in the descending aorta signify impaired systemic perfusion in preterm infants?. Pediatr Res. 2008;63:89–94
  19. Evans N. Support of the preterm circulation: keynote address to the Fifth Evidence vs Experience Conference, Chicago, June 2008. J Perinatol. 2009;29:S507
  20. Sarkar S, Dechert R, Schumacher RE, Donn SM. Is refractory hypotension in preterm infants a manifestation of early ductal shunting?. J Perinatol. 2007;27:353–358
  21. Amin SB, Handley C, Carter-Pokras O. Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States. Pediatr Cardiol. 2007;28:193–200
  22. Hoellering AB, Cooke L. The management of patent ductus arteriosus in Australia and New Zealand. J Paediatr Child Health. 2009;45:204–209
  23. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2002;CD000174
  24. Kluckow M, Evans N. Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr. 1995;127:774–779
  25. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003;CD003745
  26. Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, et al. A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen l-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72hours of birth in extremely low-birth-weight infants. Am J Perinatol. 2009;26:235–245
  27. Urquhart DS, Nicholl RM. How good is clinical examination at detecting a significant patent ductus arteriosus in the preterm neonate?. Arch Dis Child. 2003;88:85–86
  28. Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A. Trial of Indomethacin Prophylaxis in Preterms Investigators. Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr. 2007;150:229–234234.e1
  29. Madan JC, Kendrick D, Hagadorn JI, Frantz ID. National Institute of Child Health and Human Development Neonatal Research Network. Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics. 2009;123:674–681
  30. In:  Skinner J,  Dale Alverson D,  Hunter S editor. Echocardiography for the neonatologist. London: Churchill Livingstone; 2000;p. 1–243
  31. Sehgal A, McNamara PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus?. Eur J Pediatr. 2009;168:907–914
  32. McNamara PJ, Sehgal A. Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed. 2007;92:F424–F427
  33. Abman SH. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology. 2007;91:283–290
  34. Musewe NN, Smallhorn JF, Benson LN, Burrows PE, Freedom RM. Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation. 1987;76:1081–1091
  35. Phillipos EZ, Robertson MA, Byrne PJ. Serial assessment of ductus arteriosus hemodynamics in hyaline membrane disease. Pediatrics. 1996;98:1149–1153
  36. Day RW, Lynch JM, White KS, Ward RM. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics. 1996;98:698–705
  37. Skinner JR, Boys RJ, Heads A, Hey EN, Hunter S. Estimation of pulmonary arterial pressure in the newborn: study of the repeatability of four Doppler echocardiographic techniques. Pediatr Cardiol. 1996;17:360–369
  38. King ME, Braun H, Goldblatt A, Liberthson R, Weyman AE. Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study. Circulation. 1983;68:68–75
  39. Skinner JR, Hunter S, Hey EN. Haemodynamic features at presentation in persistent pulmonary hypertension of the newborn and outcome. Arch Dis Child Fetal Neonatal Ed. 1996;74:F26–F32
  40. Evans N, Kluckow M, Currie A. Range of echocardiographic findings in term neonates with high oxygen requirements. Arch Dis Child Fetal Neonatal Ed. 1998;78:F105–F111
  41. Peterson AL, Deatsman S, Frommelt MA, Mussatto K, Frommelt PC. Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn. Pediatr Cardiol. 2009 Feb;30:160–165
  42. Konduri GG, Kim UO. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatr Clin North Am. 2009;56:579–600
  43. Thébaud B, Tibboel D. Pulmonary hypertension associated with congenital diaphragmatic hernia. Cardiol Young. 2009;19:49–53
  44. Cheung PY, Barrington KJ. The effects of dopamine and epinephrine on hemodynamics and oxygen metabolism in hypoxic anesthetized piglets. Crit Care. 2001;5:158–166
  45. Tourneux P, Rakza T, Bouissou A, Krim G, Storme L. Pulmonary circulatory effects of norepinephrine in newborn infants with persistent pulmonary hypertension. J Pediatr. 2008;153:345–349
  46. McNamara PJ, Laique F, Muang-In S, Whyte HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care. 2006;21:217–222
  47. Shah PS, Ohlsson A. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. Jul 18 2007;CD005494
  48. Patel N, Mills JF, Cheung MM. Use of the myocardial performance index to assess right ventricular function in infants with pulmonary hypertension. Pediatr Cardiol. 2009;30:133–137
  49. Patel N, Mills JF, Cheung MM. Assessment of right ventricular function using tissue Doppler imaging in infants with pulmonary hypertension. Neonatology. 2009;96:193–199
  50. Nestaas E, Støylen A, Brunvand L, Fugelseth D. Tissue Doppler derived longitudinal strain and strain rate during the first 3days of life in healthy term neonates. Pediatr Res. 2009;65:357–362
  51. Wyckoff MH, Perlman JM, Laptook AR. Use of volume expansion during delivery room resuscitation in near-term and term infants. Pediatrics. 2005;115:950–955
  52. Ranjit MS. Cardiac abnormalities in birth asphyxia. Indian J Pediatr. 2000;67:52932
  53. Barberi I, Calabrò MP, Cordaro S, Gitto E, Sottile A, Prudente D, et al. Myocardial ischaemia in neonates with perinatal asphyxia. Electrocardiographic, echocardiographic and enzymatic correlations. Eur J Pediatr. 1999;158:742–747
  54. Wei Y, Xu J, Xu T, Fan J, Tao S. Left ventricular systolic function of newborns with asphyxia evaluated by tissue Doppler imaging. Pediatr Cardiol. 2009;30(6):7416
  55. Robel-Tillig E, Knüpfer M, Pulzer F, Vogtmann C. Cardiovascular impact of dobutamine in neonates with myocardial dysfunction. Early Hum Dev. 2007;83:30712
  56. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699–1713
  57. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588–595
  58. Klijn E, Den Uil CA, Bakker J, Ince C. The heterogeneity of the microcirculation in critical illness. Clin Chest Med. 2008 Dec;29:643–654
  59. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: sepsis is a disease of the microcirculation. Crit Care. 2004;8:462–468
  60. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377
  61. de Oliveira CF, de Oliveira DS, Gottschald AF, Moura JD, Costa GA, Ventura AC, et al. ACCM/PALS haemodynamic support guidelines for paediatric septic shock: an outcomes comparison with and without monitoring central venous oxygen saturation. Intensive Care Med. 2008;34:1065–1075
  62. Ceneviva G, Paschall JA, Maffei F, Carcillo JA. Hemodynamic support in fluid-refractory pediatric septic shock. Pediatrics. 1998;102:e19
  63. Brierley J, Peters MJ. Distinct hemodynamic patterns of septic shock at presentation to pediatric intensive care. Pediatrics. 2008;122:752–759
  64. Meadow W, Rudinsky B. Inflammatory mediators and neonatal sepsis. Rarely has so little been known by so many about so much. Clin Perinatol. 1995;22:519–536
  65. de Waal KA, Evans N. Hemodynamic presentation of late onset sepsis in preterm infants. J Paediatr Child Health. 2009;45:A84
  66. Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009;37:666–688
  67. Metrangolo L, Fiorillo M, Friedman G, Silance PG, Kahn RJ, Novelli GP, et al. Early hemodynamic course of septic shock. Crit Care Med. 1995;23:1971–1975
  68. Skinner JR. Echocardiography on the neonatal unit: a job for the neonatologist or the cardiologist?. Arch Dis Child. 1998;78:401–402
  69. Whitehall J. Echocardiography by a neonatologist. Arch Dis Child. 1999;80:580–581
  70. Moss S, Kitchiner DJ, Yoxall CW, Subhedar NV. Evaluation of echocardiography on the neonatal unit. Arch Dis Child Fetal Neonatal Ed. 2003;88:F287–F289
  71. CD-Rom, Evans N, Malcolm G (2006) Practical echocardiography for the neonatologist: Part 1. Normal 2D imaging and Doppler: an interactive multimedia CDROM. Royal Prince Alfred Hospital, Sydney, Australia.
  72. Australian New Zealand Clinical Trials Registry. Targeting of treatment of the patent ductus arteriosus using early echocardiography (DETECT). ID# ACTRN 12608000295347. Retrieved December 2009 at http://www.anzctr.org.au.

PII: S0378-3782(10)00041-1

doi: 10.1016/j.earlhumdev.2010.01.030

Early Human Development
Volume 86, Issue 3 , Pages 149-154 , March 2010